Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ryan Lynch currently holds 12,378 shares of CONCERT PHARMACEUTICALS, INC. (CNCE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan Lynch has been a net seller of CNCE stock. They have purchased $0 and sold $50.8K worth of shares.
Ryan Lynch's most recent insider trade was on Dec 15, 2025, when they sold 4,000 shares at $0.00 per share.
Ryan Lynch serves as Executive at CONCERT PHARMACEUTICALS, INC. (CNCE). They have executed 8 insider transactions totaling $50.8K over their tenure at the company.
Ryan Lynch holds the position of Executive at CONCERT PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Ryan Lynch has shown a selling trading pattern, with $0 in total purchases and $50.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ryan Lynch was on Sep 14, 2017, when they sold $50.8K worth of CNCE shares. This transaction involved 3,500 shares at $14.51 per share.
Ryan Lynch currently owns 12,378 shares of CONCERT PHARMACEUTICALS, INC. (CNCE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ryan Lynch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ryan Lynch has 8 Form 4 filings on record as an insider at CONCERT PHARMACEUTICALS, INC..
Set alerts for Ryan Lynch and 40,000+ other insiders.